Yu Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yu Qin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Chenye Yang
State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China
2 shared publicationsYanmei Xu
State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China
2 shared publications- Hui Huang
Materdicine Lab, School of Life Sciences Shanghai University Shanghai China
1 shared publication - Jianqiao Zhou
Department of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
1 shared publication - Jingying Zhai
Academy for Advanced Interdisciplinary Studies, Southern University of Science and Technology, Shenzhen, 518055, China
1 shared publication - Meixiang Zhang
Department of Ultrasound Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P. R. China
1 shared publication
Latest Publications
- Open Access
- 14 February 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (7) , eadt8451
Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy
Cuproptosis, a distinct cell death pathway, has been integrated into nanomedicine for disease theranostics. However, current nanosystems inducing cuproptosis rely on exogenous toxic copper ions, limiting the scope of biomaterials. Developing nanoplatforms that induce cuproptosis without exogenous copper holds substantial promise. Here, we engineered a two-dimensional iron (Fe) single-atom–doped molybdenum disulfide (MoS 2 ) piezocatalyst (Fe-MoS 2 ) for tumor therapy. Incorporating single Fe atoms enhances MoS 2 piezoelectric polarization via charge redistribution and modulates Fe and Mo oxidation states, enabling multifaceted enzymatic activities, including peroxidase-, glutathione oxidase–, oxidase-, and catalase-like activities. Upon ultrasound stimulation, the Fe-MoS 2 nanocatalyst generates reactive oxygen species and depletes glutathione via synergistic piezocatalytic and enzyocatalytic effects, disrupting copper ion homeostasis and inducing cuproptosis, concurrently triggering ferroptosis and ferritinophagy, which collectively enhances tumor suppression. This study represents the first paradigm to introduce a copper-free piezocatalyst for initiating cuproptosis, substantially advancing the applications of cuproptosis in tumor therapy.
- 14 February 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (7) , eadt8451
Open AccessSingle-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy
Cuproptosis, a distinct cell death pathway, has been integrated into nanomedicine for disease theranostics. However, current nanosystems inducing cuproptosis rely on exogenous toxic copper ions, limiting the scope of biomaterials. Developing nanoplatforms that induce cuproptosis without exogenous copper holds substantial promise. Here, we engineered a two-dimensional iron (Fe) single-atom–doped molybdenum disulfide (MoS 2 ) piezocatalyst (Fe-MoS 2 ) for tumor therapy. Incorporating single Fe atoms enhances MoS 2 piezoelectric polarization via charge redistribution and modulates Fe and Mo oxidation states, enabling multifaceted enzymatic activities, including peroxidase-, glutathione oxidase–, oxidase-, and catalase-like activities. Upon ultrasound stimulation, the Fe-MoS 2 nanocatalyst generates reactive oxygen species and depletes glutathione via synergistic piezocatalytic and enzyocatalytic effects, disrupting copper ion homeostasis and inducing cuproptosis, concurrently triggering ferroptosis and ferritinophagy, which collectively enhances tumor suppression. This study represents the first paradigm to introduce a copper-free piezocatalyst for initiating cuproptosis, substantially advancing the applications of cuproptosis in tumor therapy.
- 8 November 2013
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 139 (1) , 52-54
A long wavelength hydrophobic probe for intracellular lipid droplets
A highly stable, long wavelength polarity sensitive probe, 8-nitrophenyl-3,5-dipiperidine-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (NPBDP), was developed for living cell imaging of intracellular lipid droplets by fluorescence microscopy.
- 8 November 2013
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 139 (1) , 52-54
A long wavelength hydrophobic probe for intracellular lipid droplets
A highly stable, long wavelength polarity sensitive probe, 8-nitrophenyl-3,5-dipiperidine-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (NPBDP), was developed for living cell imaging of intracellular lipid droplets by fluorescence microscopy.